Paper42907136PubMed
Cell-based therapies for malignant glioma.
Mooney R and 5 others. Stem Cells Transl Med, 2026.
Cite this record
ConductScience Library. Cell-based therapies for malignant glioma. Papers, record 42907136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42907136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cell-based therapies for malignant glioma.
- Journal
- Stem Cells Transl Med
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-11-01
Source PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glioma | Major topic |
| Brain Neoplasms | Major topic |
| Cell- and Tissue-Based Therapy | Major topic |
| Humans | |
| Animals | |
| Immunotherapy, Adoptive | |
| Killer Cells, Natural |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Ben & Catherine Ivy Foundation | PubMed | |||
| CLIN1-14845 | Rosalinde and Arthur Gilbert Foundation, the Alvarez Charitable Foundation, City of Hope, California Instistute of Regenerative Medicine | PubMed | ||
| CIRM CLIN2-13162 | Rosalinde and Arthur Gilbert Foundation, the Alvarez Charitable Foundation, City of Hope, California Instistute of Regenerative Medicine | PubMed |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40938661 | Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/40938661 | PubMed |
| 2 | 40386781 | An update on the clinical trial research of immunotherapy for glioblastoma. | Front Immunol | 2025 | https://conductscience.org/library/papers/40386781 | PubMed |
| 3 | 37148198 | Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma. | Neuro Oncol | 2023 | https://conductscience.org/library/papers/37148198 | PubMed |
| 4 | 40190555 | Integrative multi-omic profiling of the neoantigen landscape of glioblastoma for the development of therapeutic vaccines reveals vast heterogeneity in immunogenic signatures. | Front Oncol | 2025 | https://conductscience.org/library/papers/40190555 | PubMed |
| 5 | 38166251 | Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy. | J Immunol | 2024 | https://conductscience.org/library/papers/38166251 | PubMed |
| 6 | 36790010 | Pseudoprogression versus true progression in glioblastoma: what neurosurgeons need to know. | J Neurosurg | 2023 | https://conductscience.org/library/papers/36790010 | PubMed |
| 7 | 34862245 | A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma. | Clin Cancer Res | 2022 | https://conductscience.org/library/papers/34862245 | PubMed |
| 8 | 36394838 | Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. | JAMA Oncol | 2023 | https://conductscience.org/library/papers/36394838 | PubMed |
| 9 | 28411277 | Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28411277 | PubMed |
| 10 | 40255400 | Single-cell and spatial transcriptomic insights into glioma cellular heterogeneity and metabolic adaptations. | Front Immunol | 2025 | https://conductscience.org/library/papers/40255400 | PubMed |
| 11 | 37875502 | Characteristics of premanufacture CD8+T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37875502 | PubMed |
| 12 | 28426845 | HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial. | JAMA Oncol | 2017 | https://conductscience.org/library/papers/28426845 | PubMed |
| 13 | 29093005 | Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma. | Cancer Res | 2018 | https://conductscience.org/library/papers/29093005 | PubMed |
| 14 | 32477944 | Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series. | Front Oncol | 2020 | https://conductscience.org/library/papers/32477944 | PubMed |
| 15 | 26873960 | Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma. | Clin Cancer Res | 2016 | https://conductscience.org/library/papers/26873960 | PubMed |
| 16 | 35903678 | Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients Receiving Heat Shock Protein Peptide Complex 96 Vaccination. | Front Oncol | 2022 | https://conductscience.org/library/papers/35903678 | PubMed |
| 17 | 32719000 | Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma. | Clin Cancer Res | 2020 | https://conductscience.org/library/papers/32719000 | PubMed |
| 18 | 32750039 | Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32750039 | PubMed |
| 19 | 38042450 | Radiation Therapy and Myeloid-Derived Suppressor Cells: Breaking Down Their Cancerous Partnership. | Int J Radiat Oncol Biol Phys | 2024 | https://conductscience.org/library/papers/38042450 | PubMed |
| 20 | 38454126 | Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial. | Nat Med | 2024 | https://conductscience.org/library/papers/38454126 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42907136
GET https://conductscience.org/api/papers/v1/42907136/references?page=2